Blood Clots

Tretten approved for genetic clotting disorder

(HealthDay)—Tretten (coagulation factor XIII A-Subunit recombinant) has been approved by the U.S. Food and Drug Administration to treat a very rare blood clotting disorder called congenital Factor XIII A-Subunit deficiency.

Dec 23, 2013
popularity not rated yet | comments 0

Gene therapy method targets tumor blood vessels

Working in mice, researchers at Washington University School of Medicine in St. Louis report developing a gene delivery method long sought in the field of gene therapy: a deactivated virus carrying a gene ...

Dec 23, 2013
popularity 5 / 5 (6) | comments 0 | with audio podcast

New test for chronic blood cancers

(Medical Xpress)—A new test for blood cancers will catch many more cases than the present test that identifies only 60 per cent.

Dec 11, 2013
popularity 5 / 5 (2) | comments 0 | with audio podcast

Latest Spotlight News

New diagnostic approach for autism in Tanzania

Autism is no stranger to the children of Tanzania. What is rare in the East African nation is access to clinical services, including reliable diagnosis and evidence-based treatments. There is no autism diagnostic ...